Neonatal azithromycin administration for prevention of infant mortality

BACKGROUND. Biannual mass azithromycin administration reduces all-cause childhood mortality in some sub-Saharan African settings, with the largest effects in children aged 1-5 months. Azithromycin has not been distributed to children <1 month due to risk of infantile hypertrophic pyloric stenosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldenburg, Catherine E., Sié, Ali, Bountogo, Mamadou, Zakane, Alphonse, Compaoré, Guillaume, Ouedraogo, Thierry, Koueta, Fla, Lebas, Elodie, Brogdon, Jessica, Nyatigo, Fanice, Doan, Thuy, Porco, Travis C., Arnold, Benjamin F., Lietman, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NEJM Group, a division of the Massachusetts Medical Society 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172759/
https://www.ncbi.nlm.nih.gov/pubmed/35692260
http://dx.doi.org/10.1056/EVIDoa2100054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172759/
https://www.ncbi.nlm.nih.gov/pubmed/35692260
http://dx.doi.org/10.1056/EVIDoa2100054

Ejemplares similares